Purple Biotech Ltd. logo

Purple Biotech Ltd.

NASDAQ:PPBT

Overview | Financials
Company Name Purple Biotech Ltd.
Symbol PPBT
Currency USD
Price 6.98
Market Cap 11,223,910
Dividend Yield 0%
52-week-range 6.04 - 36
Industry Biotechnology
Sector Healthcare
CEO Mr. Isaac Israel
Website https://purple-biotech.com

An error occurred while fetching data.

About Purple Biotech Ltd.

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which

Related Stocks

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.3 USD

Molecular Templates, Inc. logo

Molecular Templates, Inc.

MTEM

1.36 USD

Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc.

BDTX

4.78 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

3.14 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

27.62 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.678 USD

Biodesix, Inc. logo

Biodesix, Inc.

BDSX

1.78 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc.

PLSE

18.73 USD

Financials

Numbers are in millions USD

Numbers are in millions USD